The structural heart devices market is witnessing significant growth as the prevalence of valvular, congenital, and other structural cardiac conditions increases worldwide. According to DelveInsight, the market was valued at USD 12.94 billion in 2025 and is anticipated to reach USD 30.62 billion by 2034, expanding at a CAGR of 10.08% from 2026 to 2034. Rising adoption of catheter-based procedures, technological innovation, expanding treatment indications, and demand for shorter recovery periods are supporting this expansion.
Structural Heart Devices Market: Increasing Burden of Cardiac Disorders
The rising incidence of structural and valvular heart diseases is creating sustained demand for advanced cardiac interventions. Aortic valve stenosis affects approximately 9 million people worldwide, while mitral regurgitation impacts nearly 24 million. Congenital conditions, including atrial septal defects, ventricular septal defects, and patent foramen ovale, further contribute to the need for corrective procedures. Without appropriate treatment, these abnormalities may result in complications such as heart failure, arrhythmias, and pulmonary hypertension, strengthening the requirement for effective repair and replacement technologies.
Structural Heart Devices Market: Advancements in Treatment Technologies
Technological progress is reshaping the management of structural cardiac disorders. New-generation transcatheter heart valves, mitral and tricuspid repair systems, annuloplasty devices, occluders, and left atrial appendage closure technologies are being designed to improve procedural accuracy and patient outcomes. Improvements in three-dimensional echocardiography, real-time imaging, and artificial intelligence-supported procedural navigation are further helping clinicians manage complex interventions. As device performance and procedural precision improve, minimally invasive treatment options are becoming accessible to a broader patient population.
Structural Heart Devices Market: Shift Toward Minimally Invasive Procedures
The increasing preference for catheter-based interventions over conventional open-heart surgery represents another major growth factor. Transcatheter procedures can potentially reduce surgical trauma, hospitalization duration, infection risk, and recovery time. These advantages are particularly relevant for elderly patients and individuals with multiple comorbidities who may not be suitable candidates for conventional surgery.
Transcatheter aortic valve replacement has consequently become an established option for numerous patients with severe aortic stenosis. Its use has progressively expanded beyond high-risk patients toward intermediate- and selected lower-risk populations, creating additional opportunities for device manufacturers.
Structural Heart Devices Market: Replacement Devices Maintain Product Leadership
Replacement devices accounted for approximately 63% of the market in 2025, making them the leading product category. This segment encompasses mechanical and tissue-based heart valves used in surgical as well as transcatheter procedures. Growing utilization of transcatheter aortic valve replacement for severe aortic stenosis has significantly contributed to demand.
Tissue valves continue to attract interest because of their favorable hemodynamic performance and reduced requirement for long-term anticoagulation compared with mechanical alternatives. Mechanical valves, meanwhile, remain important because of their durability and suitability for patients requiring long-term valve replacement.
Repair technologies are also gaining traction as transcatheter mitral and tricuspid procedures advance. Improvements in annuloplasty systems, occluders, and other repair technologies are expected to expand the range of patients who can benefit from less invasive structural heart interventions.
Structural Heart Devices Market: Atrial Septal Defect Leads Applications
Atrial septal defect represented approximately 29% of the market in 2025, making it the largest application segment. The segment's prominence is associated with the prevalence of congenital cardiac abnormalities and increasing utilization of catheter-delivered occluder devices.
These devices allow physicians to close cardiac defects without traditional open-heart surgery, potentially supporting reduced procedural trauma and faster recovery. Continued improvements in device architecture, cardiac imaging, and diagnosis are expected to contribute to demand for ASD treatment technologies.
Structural Heart Devices Market: Hospitals Dominate End-User Demand
Hospitals represented approximately 45% of the market in 2025 and remained the leading end-user segment. Structural heart interventions frequently require sophisticated catheterization laboratories, hybrid operating facilities, specialized imaging systems, and multidisciplinary cardiac teams.
As increasingly complex transcatheter procedures are introduced, hospitals are strengthening their cardiovascular infrastructure and expanding specialist capabilities. Ambulatory surgical centers may gain importance for selected lower-risk procedures, but hospitals are expected to retain their leading position because many structural heart interventions require advanced facilities and specialized expertise.
Structural Heart Devices Market: Regional Expansion Supports Future Growth
Regional dynamics are expected to significantly influence future industry development. North America accounted for approximately 50% of global market revenue in 2025, supported by advanced interventional cardiology infrastructure, established reimbursement systems, clinical research capabilities, and the presence of leading device manufacturers. Asia-Pacific is expected to record comparatively rapid growth as healthcare investment, cardiovascular disease prevalence, and access to specialized cardiac services increase.
The india structural heart devices market presents an emerging opportunity as cardiovascular disease burden rises and interventional cardiology capabilities expand. Improvements in healthcare infrastructure, greater awareness of minimally invasive treatment, and increasing availability of advanced cardiac procedures could support market development.
The gcc structural heart devices market is also gaining attention as Gulf nations continue developing sophisticated healthcare facilities and specialized cardiovascular services. At the same time, the uk structural heart devices market is supported by an established healthcare ecosystem and a considerable prevalence of valve disease among older populations. DelveInsight estimates that heart valve disease affects approximately 11.29% of people aged 65 years and older in the United Kingdom.
Structural Heart Devices Market: European and South American Opportunities
The france structural heart devices market is positioned for continued development as demand for advanced cardiovascular procedures and minimally invasive treatment options increases. Growing clinical adoption and technological progress are supporting opportunities for structural heart device manufacturers across European healthcare systems.
The south america structural heart devices market also offers long-term potential as healthcare infrastructure develops and access to specialized cardiac interventions improves. DelveInsight's assessment covers major markets across North America, Europe, Asia-Pacific, the Middle East, Africa, and South America, providing insights into regional trends and competitive opportunities.
Structural Heart Devices Market: Competitive Environment and Innovation
The competitive landscape includes major companies such as Medtronic, Boston Scientific Corporation, Edwards Lifesciences, Abbott, Braile Biomedica, JOTEC GmbH, Valcare Medical, W. L. Gore & Associates, Cardiovascular Systems, and XELTIS BV. Competition is being shaped by product launches, regulatory approvals, clinical evidence, strategic partnerships, acquisitions, and investment in next-generation technologies.
Recent innovation has focused on transcatheter valve platforms, mitral and tricuspid repair systems, and restorative valve technologies. Companies are increasingly emphasizing device durability, procedural efficiency, patient selection, and improved clinical outcomes to strengthen their positions in the evolving structural cardiac intervention landscape.
Structural Heart Devices Market: Outlook and Emerging Opportunities
Despite favorable growth prospects, the industry faces challenges related to regulatory requirements, high research and development expenditure, specialized infrastructure needs, reimbursement differences, and device safety considerations. Manufacturers must also demonstrate strong clinical outcomes while navigating increasingly sophisticated regulatory and healthcare environments.
Nevertheless, population aging, the growing burden of cardiovascular disease, rising acceptance of minimally invasive procedures, and continuous advances in cardiac technologies are expected to sustain market expansion. The projected increase from USD 12.94 billion in 2025 to USD 30.62 billion by 2034 highlights the growing importance of structural heart interventions within the broader field of interventional cardiology.
Latest Reports by DelveInsight:
osteochondrodysplasias market | pachyonychia congenita market | recurrent pericarditis market | small fiber neuropathy market | sts devices market | thymic carcinoma market | acute pancreatitis market | anemia in chronic kidney disease market | endometrial hyperplasia market | metabolic acidosis market | primary open-angle glaucoma market | egfr-induced skin disorders market | diamond blackfan anemia market | rheumatoid arthritis market | tongue cancer market | astigmatism market | chronic pancreatitis market | cardiovascular calcification market | anca vasculitis market | foot and ankle devices market | tumor ablation market | cervical cancer market | chronic neuropathic pain market | chronic obstructive pulmonary disease copd market
About DelveInsight
DelveInsight is a leading Business Consulting and Market Research firm dedicated to the life sciences sector. It supports Pharma companies with comprehensive end-to-end solutions designed to enhance business performance. It also provides Healthcare Consulting Services that enable effective market analysis, accelerate business growth, and help organizations overcome challenges through a practical and strategic approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Abhishek kumar
Email: abhishek@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek